Open Beta
TREN
MetriLume
TREN

US marketsISCO

SEC-sourced researchBeta

ISCO

International Stem Cell CORP

Company comparison ↗

Data passport

CIK
0001355790
Exchange
OTC
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 17, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 9,085,000.0000 USD; December 2025: 9,100,000.0000 USD9.1M USD0 USD0December 2024December 2025
ISCO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20249,085,000.0000Mar 30, 2026
December 20259,100,000.0000Mar 30, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20259,100,000.0000-418,000.00008,000.00004,819,000.00004,579,000.0000Mar 30, 2026
December 20249,085,000.0000-209,000.000013,000.00005,173,000.00004,803,000.0000Mar 30, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$9.1MDecember 2025Mar 30, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$9.09MDecember 2024Mar 30, 202610-K
Net incomeNetIncomeLoss-$418KDecember 2025Mar 30, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$8KDecember 2025Mar 30, 202610-K
Total assetsAssets$4.82MDecember 2025Mar 30, 202610-K
Total liabilitiesLiabilities$4.58MDecember 2025Mar 30, 202610-K

New filings

Explore methodology ↗